Efficacy of Liquid Embolic Agent Treatment in Hemorrhagic Peripheral Intracranial Aneurysms: A Single-Center Experience.

Efficacy of Liquid Embolic Agent Treatment in Hemorrhagic Peripheral Intracranial Aneurysms: A Single-Center Experience.
复制标题

DOI:
10.3390/brainsci12091264
复制
发表时间:
2022-09-19
期刊:
影响因子:
3.3
通讯作者:
Zhang, Qing-Rong
Zhang, Qing-Rong
中科院分区:
医学4区
文献类型:
--
作者:
Zhuang, Zong;Zhu, Qi;Liu, Xun-Zhi;Ling, Hai-Ping;Na, Shi-Jie;Liu, Tao;Zhang, Yu-Hua;Hang, Chun-Hua;Liu, Kai-Dong;Zhang, Qing-Rong

文献摘要

参考文献

相似文献

目的:评价液体栓塞剂治疗各种出血性颅内周围动脉瘤的疗效。研究方法:我们回顾性分析了38例患有出血性周围颅内动脉瘤并接受液体栓塞剂治疗的患者。术后6个月采用改良兰金量表进行随访,术后6个月进行数字减影血管造影随访。结果如下:38例(单纯外周动脉瘤10例,烟雾病(Moyamoya disease,MMD)6例,动静脉畸形(AVM)22例)中,后循环动脉瘤最多(57.9%),其次为前循环动脉瘤(21.1%)和颅内动脉瘤(21.1%)。4例发生术中出血,4例发生术后脑梗死,2例发生微导管留置,1例动静脉畸形患者基底动脉发生术中血栓形成。仅1例患者发生术后出血。在6个月随访时,84.2%的患者预后良好,13.5%的患者预后不良。结论:液体栓塞剂是治疗出血性颅内外周动脉瘤的有效药物,但其安全性取决于动脉瘤的亚型。对于MMD的外周出血性动脉瘤,栓塞前必须仔细评估血管结构。
Objective: To evaluate the efficacy of liquid embolization agents for treating various hemorrhagic peripheral intracranial aneurysms. Methods: We retrospectively analyzed 38 patients who suffered from hemorrhagic peripheral intracranial aneurysms and were treated with liquid embolization agents. We used the modified Rankin scale for follow-up at 6 months postoperatively, and digital subtraction angiography follow-up was performed 6 months postoperatively. Results: Of the 38 patients (ten of simple peripheral intracranial aneurysms, six of Moyamoya disease (MMD), and 22 of arteriovenous malformation (AVM)), posterior circulation accounted for the most significant proportion (57.9%), followed by anterior circulation (21.1%) and intranidal aneurysms (21.1%). Intraoperative hemorrhage occurred in four cases, postoperative cerebral infarction occurred in four cases, two patients encountered microcatheter retention, and intraoperative thrombosis took place in the basilar artery of a patient with an arteriovenous malformation. A postoperative hemorrhage occurred in only one patient. At 6-month follow-up, 84.2% of patients had good prognosis outcomes, and 13.5% had poor outcomes. Conclusion: Liquid embolization agents are effective for hemorrhagic peripheral intracranial aneurysms; however, safety depends on the subtypes. For peripheral hemorrhagic aneurysms in MMD, the vessel architecture must be carefully evaluated before embolization.
DOI: 10.1177/159101990300900303
发表时间: 2003-09-01
影响因子: 1.7
作者:
Leonardi, M;Cenni, P;Fini, G
通讯作者: Fini, G
DOI: 10.3389/fneur.2020.570198
发表时间: 2020
影响因子: 3.4
作者:
Chen Y;Li R;Ma L;Zhao Y;Yu T;Wang H;Ye X;Wang R;Chen X;Zhao Y
通讯作者: Zhao Y
DOI: 10.1161/strokeaha.117.017866
发表时间: 2017-07
期刊: Stroke
影响因子: 8.3
作者:
Broderick JP;Adeoye O;Elm J
通讯作者: Elm J
DOI: 10.3171/2008.6.jns0814
发表时间: 2009-01-01
影响因子: 4.1
作者:
Nussbaum, Eric S.;Madison, Michael T.;Nussbaum, Leslie A.
通讯作者: Nussbaum, Leslie A.
DOI: 10.1080/02688697.2020.1781058
发表时间: 2020-06-19
影响因子: 1.1
作者:
Zhao, Xu;Wang, Xiaofei;Wang, Chengwei
通讯作者: Wang, Chengwei